Founded by three of the world’s leading authorities in neuroscience, medicine and computer science, Mindstrong Health is redefining behavioral healthcare by redefining how care providers will diagnose and manage brain disorders.
Mindstrong’s technology will – for the first time - give patients and providers a seamless and instantaneous method to objectively and continuously measure mood, cognition, and behavior in the home and work environment, delivering insights not possible with traditional clinical, neuropsychological, and imaging techniques.
Mindstrong builds on one of the founder’s digital biomarker platform developed over years of extensive R&D.
Our Values : Science That Makes a Difference.
Measuring Success: Changing Minds and Fixing brains.
Paul Dagum, MD & PhD
Paul Dagum, M.D., Ph.D. is an entrepreneur, scientist and technologist with a track record of creating and launching products in three successful venture-backed companies. Dr. Dagum led NSF and NIH grants while at Stanford University, published over 70 peer-review articles and book chapters in computer science and medicine, and was awarded over 20 patents. Dr. Dagum received an MSc in theoretical physics, PhD in theoretical computer science both from the University of Toronto and an MD from Stanford University.
Tom Insel, MD
Thomas R. lnsel, M.D. is a psychiatrist and neuroscientist. From 2002-2015, Dr. Insel served as Director of the National Institute of Mental Health (NIMH), the component of the National Institutes of Health (NIH) committed to research on mental disorders. Most recently he led the Mental Health Team at Verily. Dr. Insel is a member of the National Academy of Medicine and has received numerous national and international awards including honorary degrees in the U.S. and Europe.
Rick Klausner, MD
Richard D. Klausner is founder and Director of Juno Therapeutics and founder and Director of GRAIL. Dr. Klausner was appointed by Presidents Clinton and Bush as the eleventh Director of the U.S. National Cancer Institute between 1995 and 2001. Dr. Klausner served as chief of the Cell Biology and Metabolism Branch of the National Institute of Child Health and Human Development, as well as a past president of the American Society of Clinical Investigation. He is a member of the National Academy of Sciences, the Institute of Medicine and the American Academy of Arts and Sciences.
Board of Directors
Mindstrong's Board of Directors bring deep experience working at the intersection of academia and industry.
Rick Klausner, MD
Founder and Executive Chairman, Mindstrong Health
President and CEO, Optum Analytics
Tom Insel, MD
Founder and President, Mindstrong Health
Robert Epstein, MD
CEO, Epstein Health
Paul Dagum, MD PHD
Founder and Chief Executive Officer, Mindstrong Health
Mindstrong’s investors have launched some of the most transformative biotechnology and healthcare companies in neuropsychiatry and neurodegeneration.
Mindstrong has developed and patented a biomarker panel that measures brain function from interaction patterns captured passively and continuously from human-computer interfaces found in ubiquitous mobile technology.